Holista Colltech Limited (ASX:HCT)

Market Cap	22.11M
Revenue (ttm)	5.60M
Net Income (ttm)	-84.21K
Shares Out	335.05M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,270
Average Volume	242,819
Open	0.0660
Previous Close	0.0660
Day's Range	0.0650 - 0.0660
52-Week Range	0.0050 - 0.0700
Beta	0.73
RSI	66.81
Earnings Date	Aug 27, 2025

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Leong Loong
• Employees: 58
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HCT

Financial Performance

In 2024, Holista Colltech's revenue was 5.60 million, a decrease of -5.86% compared to the previous year's 5.95 million. Losses were -84,214, -98.25% less than in 2023.